These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6332093)

  • 1. Evaluation of various cytostatic drugs as local immunotherapeutic agents.
    Scheper RJ; Vos A; de Groot J; Boerrigter GH
    Invest New Drugs; 1984; 2(2):221-5. PubMed ID: 6332093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.
    Boerrigter GH; Scheper RJ
    Clin Exp Immunol; 1984 Oct; 58(1):161-6. PubMed ID: 6478648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor regression and induction of anti-tumor immunity by local chemotherapy of guinea-pigs bearing a line-10 hepatocarcinoma.
    Claessen AM; Valster H; Bril H; Steerenberg PA; Tan BT; Scheper RJ
    Int J Cancer; 1991 Feb; 47(4):626-32. PubMed ID: 1995491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation.
    Claessen AM; Valster H; Bril H; Meyer S; Scheper RJ
    Cancer Immunol Immunother; 1989; 28(2):131-5. PubMed ID: 2917364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal administration of 4-hydroperoxy-cyclophosphamide during contact sensitization potentiates effector T cell responsiveness in draining lymph nodes.
    Boerrigter GH; de Groot J; Scheper RJ
    Immunopharmacology; 1986 Feb; 11(1):13-20. PubMed ID: 3485619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effects of locally administered cytostatic drugs on T effector cell functions in mice.
    Limpens J; Garssen J; Germeraad WT; Scheper RJ
    Int J Immunopharmacol; 1990; 12(1):77-88. PubMed ID: 2303320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local administration of cytostatic drugs enhances delayed-type hypersensitivity to Sendai virus in mice.
    Limpens J; Garssen J; Scheper RJ
    Clin Immunol Immunopathol; 1990 Jan; 54(1):161-5. PubMed ID: 2152858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytostatic agents and contact allergy: the efferent limb.
    Anderson CD; Groth O
    Contact Dermatitis; 1985 Jan; 12(1):24-32. PubMed ID: 3979041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative.
    Limpens J; Van Meijer M; Van Santen HM; Germeraad WT; Hoeben-Schornagel K; Breel M; Scheper RJ; Kraal G
    Immunology; 1991 Jul; 73(3):255-63. PubMed ID: 1879874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local administration of various cytostatic drugs after subcutaneous immunization enhances delayed-type hypersensitivity reaction to sheep red blood cells in mice.
    Tan BT; Limpens J; Koken M; Valster H; Scheper RJ
    Scand J Immunol; 1986 May; 23(5):605-9. PubMed ID: 2939555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro and in vivo experiments on the immunosuppressive properties of cytostatic substances (author's transl)].
    Schuppli R
    Dermatologica; 1976; 152(5):289-94. PubMed ID: 955228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclophosphamide on immunological control mechanisms.
    Turk JL; Parker D
    Immunol Rev; 1982; 65():99-113. PubMed ID: 6214496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of a new "paramunity" inducer (PIND-AVI) for human beings and animals].
    Stickl H; Mayr A
    Fortschr Med; 1979 Oct; 97(40):1781-8. PubMed ID: 232054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic effects of local chemotherapy with an active metabolite of cyclophosphamide.
    Scheper RJ; Limpens J; Tan BT; Valster H; Claessen AM; Claessen ME
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):611-5. PubMed ID: 3325717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of T-lymphocyte function by bleomycin.
    Parker D; Turk JL
    Immunopharmacology; 1984 Apr; 7(2):109-13. PubMed ID: 6202656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of established tumors and induction of tumor immunity by intratumor chemotherapy.
    Bast RC; Segerling M; Ohanian SH; Greene SL; Zbar B; Rapp HJ; Borsos T
    J Natl Cancer Inst; 1976 Apr; 56(4):829-32. PubMed ID: 176411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of dependence on cyclophosphamide-sensitive suppressor cells in suppression of cell-mediated immunity by cyclosporine in the guinea pig.
    Thomson AW; Aldridge RD
    Transplantation; 1984 Jul; 38(1):76-7. PubMed ID: 6234688
    [No Abstract]   [Full Text] [Related]  

  • 18. PEG-IL-2 therapy of advanced cancer in the guinea pig. Impact of the primary tumor and beneficial effect of cyclophosphamide.
    Balemans LT; Steerenberg PA; Koppenhagen FJ; Kremer BH; De Mulder PH; Claessen AM; Scheper RJ; Den Otter W
    Int J Cancer; 1994 Sep; 58(6):871-6. PubMed ID: 7927881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the effect of a single dose of cyclosporin-A on antibody and cell mediated immune responses in the guinea pig.
    Parker D; Drössler K; Turk JL
    Int J Immunopharmacol; 1984; 6(1):67-74. PubMed ID: 6609892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low allergenicity of clonidine impedes studies of sensitization mechanisms in guinea pig models.
    Scheper RJ; von Blomberg BM; de Groot J; Goeptar AR; Lang M; Oostendorp RA; Bruynzeel DP; van Tol RG
    Contact Dermatitis; 1990 Aug; 23(2):81-9. PubMed ID: 2209009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.